---
figid: PMC8999734__ijms-23-03986-g004
figtitle: Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing
  TAK1 in AP-1 Pathway
organisms:
- NA
pmcid: PMC8999734
filename: ijms-23-03986-g004.jpg
figlink: /pmc/articles/PMC8999734/figure/ijms-23-03986-f004/
number: F4
caption: Schematic representation of Loratadine targeting the AP-1 signaling pathway.
  Loratadine specifically inhibits TAK1 in the AP-1 signaling pathway upon LPS induction,
  thereby suppressing the constituent kinases of the AP-1 pathway and eventually reducing
  the production of pro-inflammatory cytokines.
papertitle: Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by
  Suppressing TAK1 in AP-1 Pathway.
reftext: Jiwon Jang, et al. Int J Mol Sci. 2022 Apr;23(7):3986.
year: '2022'
doi: 10.3390/ijms23073986
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Loratadine | anti-inflammatory effect | AP-1 | TAK1
automl_pathway: 0.9408578
figid_alias: PMC8999734__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8999734__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8999734__ijms-23-03986-g004.html
  '@type': Dataset
  description: Schematic representation of Loratadine targeting the AP-1 signaling
    pathway. Loratadine specifically inhibits TAK1 in the AP-1 signaling pathway upon
    LPS induction, thereby suppressing the constituent kinases of the AP-1 pathway
    and eventually reducing the production of pro-inflammatory cytokines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR4
  - MYD88
  - TRIM69
  - TICAM1
  - MAP3K7
  - NR2C2
  - MAP2K7
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - FOS
  - FOSB
  - JUNB
  - JUND
  - IRF6
  - MMP1
  - MMP9
  - MMP3
  - PTGS2
---
